Maciej Tatarczuch

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.

Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.

Journal: Neuro-oncology advances

Published: June 27, 2025

Time to revisit reduced-dose radiotherapy for PCNSL?

Time to revisit reduced-dose radiotherapy for PCNSL?

Journal: Blood advances

Published: December 12, 2024

A critical analysis of CellaVision systems in the modern hematology laboratory.

A critical analysis of CellaVision systems in the modern hematology laboratory.

Journal: American journal of clinical pathology

Published: December 09, 2024

Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.

Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.

Journal: EJHaem

Published: May 09, 2024

Time to Be Launched 1 auXiliary Risk strat1fier in marginal zone lymphoma transformation: TBL1XR1.

Time to Be Launched 1 auXiliary Risk strat1fier in marginal zone lymphoma transformation: TBL1XR1.

Journal: Cancer

Published: February 14, 2024

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.

Journal: Blood advances

Published: December 02, 2022

Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Journal: Internal medicine journal

Published: May 15, 2021

Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy.

Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy.

Journal: Leukemia & lymphoma

Published: September 28, 2020

Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy.

Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy.

Journal: Research and practice in thrombosis and haemostasis

Published: January 22, 2020

Resource implications of bortezomib therapy in a large UK cohort: An evaluation study.

Resource implications of bortezomib therapy in a large UK cohort: An evaluation study.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: August 09, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026